The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice
Transplant International · 2023
DOI: 10.3389/ti.2023.11321 ↗Kurz gefasst
Leitlinie in der Zeitschrift Transplant International, 2023. Verfasst von Dennis A J van den Broek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Leiden Transplant Center, Leiden University Medical Center, Leiden University, Leiden, Netherlands. Hauptthemen laut MEDLINE: Kidney Transplantation, Organ Transplantation. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Solid phase immunoassays improved the detection and determination of the antigen-specificity of donor-specific antibodies (DSA) to human leukocyte antigens (HLA). The widespread use of SPI in kidney transplantation also introduced new clinical dilemmas, such as whether patients should be monitored for DSA pre- or post-transplantation. Pretransplant screening through SPI has become standard practice and DSA are readily determined in case of suspected rejection. However, DSA monitoring in recipients with stable graft function has not been universally established as standard of care. This may be related to uncertainty regarding the clinical utility of DSA monitoring as a screening tool. This consensus report aims to appraise the clinical utility of DSA monitoring in recipients without overt signs of graft dysfunction, using the Wilson & Junger criteria for assessing the validity of a screening practice. To assess the evidence on DSA monitoring, the European Society for Organ Transplantation (ESOT) convened a dedicated workgroup, comprised of experts in transplantation nephrology and immunology, to review relevant literature. Guidelines and statements were developed during a consensus conference by Delphi methodology that took place in person in November 2022 in Prague. The findings and recommendations of the workgroup on subclinical DSA monitoring are presented in this article.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Leiden Transplant Center, Leiden University Medical Center, Leiden University, Leiden, Netherlands.
- Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany.
- Paris Translational Research Center for Organ Transplantation, Kidney Transplant Department, Saint Louis Hospital, Université de Paris Cité, Paris, France.
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, Transplant Immunology Unit, Padua University Hospital, Padua, Italy.
- Department of Nephrology, Transplantation and Hemodialysis, Rouen University Hospital, Rouen, France.
- Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain.
Förderung
- Medical Research Council
Zitieren
APA
van den Broek, D. A. J., Meziyerh, S., Budde, K., Lefaucheur, C., Cozzi, E., Bertrand, D., López Del Moral, C., Dorling, A., Emonds, M. P., Naesens, M., de Vries, A. P. J., & ESOT Working Group Subclinical DSA Monitoring (2023). The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice. Transplant International. https://doi.org/10.3389/ti.2023.11321
Vancouver
van den Broek DAJ, Meziyerh S, Budde K, Lefaucheur C, Cozzi E, Bertrand D, et al. The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice. Transplant International. 2023. doi:10.3389/ti.2023.11321
BibTeX
@article{vandenBroek2023,
author = {van den Broek, Dennis A J and Meziyerh, Soufian and Budde, Klemens and Lefaucheur, Carmen and Cozzi, Emanuele and Bertrand, Dominique and López Del Moral, Covadonga and Dorling, Anthony and Emonds, Marie-Paule and Naesens, Maarten and de Vries, Aiko P J and ESOT Working Group Subclinical DSA Monitoring, ESOT Working Group Subclinical DSA Monitoring},
title = {The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice},
journal = {Transplant International},
year = {2023},
doi = {10.3389/ti.2023.11321}
}
EUVIMED